Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E V Privalova

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Kardiologiia|January 21, 2022
[Assessment of the structural and functional state of blood vessels in patients with hypertrophic cardiomyopathy]F M Bogatyreva, V Ra Yu Kaplunova, M V Kozhevnikova, et al.
Klinicheskaia Meditsina|July 26, 2002
[Pulmonary hypertension in interstitial diseases of the lungs]D V Arkhipova, B M Kornev, E N Popova, et al.
Kardiologiia|February 16, 2022
Possible pathway for heart failure with preserved ejection fraction prevention and treatment: the angiotensin-converting enzyme inhibitor effect on endothelial function in comorbid patientsJu I Safonova, M V Kozhevnikova, Yu A Danilogorskaya, et al.
Terapevticheskii Arkhiv|March 20, 2026
[Analysis of external respiratory function disturbances in combined pulmonary fibrosis and emphysema]N V Markov, N A Khodorik, M M Ilkovich, et al.
Terapevticheskii Arkhiv|April 28, 2004
[Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension]D V Arkhipova, E V Privalova, L V Kozlovskaia, et al.
Klinicheskaia Meditsina|March 21, 2000
[Enalapril treatment of residual pulmonary hypertension in patients operated rheumatic mitral valve defects]E V Privalova, V I Ershov, A I Ermakov, et al.
Kardiologiia|March 1, 1991
[Predicting the volume and hemodynamic outcome of radical correction of tetralogy of Fallot on the basis of angio- morphometry]A S Ivanov, A L Mishnaevskiĭ, L P Cherepenin, et al.
Kardiologiia|June 2, 2011
[Comparative analysis of antioxidant activity of nebivolol in patients with chronic heart failure with and without concomitant type 2 diabetes]Iu N Belenkov, E V Privalova, I S Chekneva, et al.
Kardiologiia|February 22, 2018
[Hypertrophic Cardiomyopathy and Ischemic Heart Disease. Variants of Combination Pathology]V Y Kaplunova, G A SHakaryants, M V Kozhevnikova, et al.
Kardiologiia|October 7, 2022
The Prognostic Value of Neuregulin-1β in Heart Failure Patients With Preserved Ejection FractionK A Zhbanov, A A Shchendrygina, E Yu Salakheeva, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Kardiologiia|January 21, 2022
[Assessment of the structural and functional state of blood vessels in patients with hypertrophic cardiomyopathy]F M Bogatyreva, V Ra Yu Kaplunova, M V Kozhevnikova, et al.
Klinicheskaia Meditsina|July 26, 2002
[Pulmonary hypertension in interstitial diseases of the lungs]D V Arkhipova, B M Kornev, E N Popova, et al.
Kardiologiia|February 16, 2022
Possible pathway for heart failure with preserved ejection fraction prevention and treatment: the angiotensin-converting enzyme inhibitor effect on endothelial function in comorbid patientsJu I Safonova, M V Kozhevnikova, Yu A Danilogorskaya, et al.
Terapevticheskii Arkhiv|March 20, 2026
[Analysis of external respiratory function disturbances in combined pulmonary fibrosis and emphysema]N V Markov, N A Khodorik, M M Ilkovich, et al.
Terapevticheskii Arkhiv|April 28, 2004
[Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension]D V Arkhipova, E V Privalova, L V Kozlovskaia, et al.
Klinicheskaia Meditsina|March 21, 2000
[Enalapril treatment of residual pulmonary hypertension in patients operated rheumatic mitral valve defects]E V Privalova, V I Ershov, A I Ermakov, et al.
Kardiologiia|March 1, 1991
[Predicting the volume and hemodynamic outcome of radical correction of tetralogy of Fallot on the basis of angio- morphometry]A S Ivanov, A L Mishnaevskiĭ, L P Cherepenin, et al.
Kardiologiia|June 2, 2011
[Comparative analysis of antioxidant activity of nebivolol in patients with chronic heart failure with and without concomitant type 2 diabetes]Iu N Belenkov, E V Privalova, I S Chekneva, et al.
Kardiologiia|February 22, 2018
[Hypertrophic Cardiomyopathy and Ischemic Heart Disease. Variants of Combination Pathology]V Y Kaplunova, G A SHakaryants, M V Kozhevnikova, et al.
Kardiologiia|October 7, 2022
The Prognostic Value of Neuregulin-1β in Heart Failure Patients With Preserved Ejection FractionK A Zhbanov, A A Shchendrygina, E Yu Salakheeva, et al.
Pageof 6